Endophthalmitis Terminated Phase 3 Trials for Moxifloxacin (DB00218)

Also known as: Ophthalmitis / Eye inflammation / Eye inflammation NOS

IndicationStatusPhase
DBCOND0009899 (Endophthalmitis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02770729Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.Prevention